abstract |
A novel antibody having excellent antibacterial activity against Pseudomonas aeruginosa is provided. By using plasmablasts from patients with chronic Pseudomonas aeruginosa pulmonary infection cystic fibrosis, antibodies successfully bind to LPS of serotype B. Pseudomonas aeruginosa strains and have good antibacterial activity in vitro and in vivo. |